150 related articles for article (PubMed ID: 1399377)
41. [Therapeutic activity of aztreonam in the treatment of acute and chronic urinary infections].
Ranno S; Bellotti MG; Raimondi A; Minaldi G
Minerva Urol Nefrol; 1986; 38(1):65-9. PubMed ID: 3738680
[No Abstract] [Full Text] [Related]
42. Randomized prospective study of the comparative efficacy of spectinomycin and gentamicin in urinary tract infections.
Sasvary DH; Tzakis AG; Smith NL; Khan SA; Soroff HS
Urol Int; 1983; 38(3):135-7. PubMed ID: 6223430
[TBL] [Abstract][Full Text] [Related]
43. [Aztreonam and aminoglycosides in the therapy of urinary infections associated with renal calculosis].
Coen G; Nazzaro L; Cipriani P; Giordano A; Mazzaferro S; Petta S; Reale MG; Smacchi A
Clin Ter; 1989 Feb; 128(4):243-9. PubMed ID: 2524313
[TBL] [Abstract][Full Text] [Related]
44. A randomized, comparative study of tobramycin and gentamicin in treatment of acute urinary tract infections.
Walker BD; Gentry LO
J Infect Dis; 1976 Aug; 134 Suppl():S146-9. PubMed ID: 787449
[TBL] [Abstract][Full Text] [Related]
45. Clinical experience with aztreonam in Germany and Austria.
Stille W; Gillissen J
Rev Infect Dis; 1985; 7 Suppl 4():S825-30. PubMed ID: 3909342
[TBL] [Abstract][Full Text] [Related]
46. The use of intravesical gentamicin to treat recurrent urinary tract infections in lower urinary tract dysfunction.
Abrams P; Hashim H; Tomson C; Macgowan A; Skews R; Warren K
Neurourol Urodyn; 2017 Nov; 36(8):2109-2116. PubMed ID: 28503891
[TBL] [Abstract][Full Text] [Related]
47. Aztreonam in the treatment of serious gram-negative infections in the elderly.
Deger F; Douchamps J; Freschi E; Thys JP; Nève P; Herchuelz A
Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):22-6. PubMed ID: 3403089
[TBL] [Abstract][Full Text] [Related]
48. [Prophylaxis in prostatic surgery with aztreonam. Our experience].
Moyano Calvo JL; Arellano Gañán R; Sempere Gutiérrez A; Sanz Sacristán J; Teba del Pino F; Melón Rey FJ; Herrero Torres L; Pereira Sanz I
Arch Esp Urol; 1992; 45(6):519-21. PubMed ID: 1510489
[TBL] [Abstract][Full Text] [Related]
49. Comparative study of aztreonam and cefamandole in the treatment of serious urinary tract infections.
Tsouroutsoglou W; Sion ML; Stathopoulos GA; Kapoulas S; El-Messidi M; Paradelis AG
Methods Find Exp Clin Pharmacol; 1983; 5(6):385-90. PubMed ID: 6684719
[TBL] [Abstract][Full Text] [Related]
50. Aztreonam: the first monobactam.
Neu HC
Med Clin North Am; 1988 May; 72(3):555-66. PubMed ID: 3280906
[TBL] [Abstract][Full Text] [Related]
51. Aztreonam therapy for serious gram-negative bacillary infections.
Cone LA; Woodard DR
Rev Infect Dis; 1985; 7 Suppl 4():S794-802. PubMed ID: 3909339
[TBL] [Abstract][Full Text] [Related]
52. Randomized comparison of aztreonam and cefuroxime in gram-negative upper urinary tract infections.
Friman G; Cars O; Bäck E; Beckman H; Carlsson M; Forssell J; Fredlund H; Neringer R; Odenholt-Tornqvist I; Rydén C
Infection; 1989; 17(5):284-9. PubMed ID: 2689345
[TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetics, in-vitro activity, therapeutic efficacy and clinical safety of aztreonam vs. cefotaxime in the treatment of complicated urinary tract infections.
Naber KG; Dette GA; Kees F; Knothe H; Grobecker H
J Antimicrob Chemother; 1986 Apr; 17(4):517-27. PubMed ID: 3710959
[TBL] [Abstract][Full Text] [Related]
54. Pharmacoeconomics of aztreonam-clindamycin versus gentamicin-clindamycin in the treatment of penetrating abdominal injury.
Fabian TC; Boucher BA; Croce MC
Pharmacotherapy; 1996; 16(5):951-7. PubMed ID: 8888092
[TBL] [Abstract][Full Text] [Related]
55. Controlled comparison of amikacin and gentamicin.
Smith CR; Baughman KL; Edwards CQ; Rogers JF; Lietman PS
N Engl J Med; 1977 Feb; 296(7):349-53. PubMed ID: 319355
[TBL] [Abstract][Full Text] [Related]
56. Role of aztreonam in urinary tract infections.
Roberts JA
Urology; 1988 Jun; 31(6 Suppl):39-44. PubMed ID: 3287749
[TBL] [Abstract][Full Text] [Related]
57. [Comparative double-blind trial of sisomicin and gentamicin in the treatment of complicated urinary tract infections (author's transl)].
Niijima T; Kondo K; Okamoto K; Eto K; Momose S; Kumazawa J; Kurokawa K; Fujimura N; Goto H; Sonoda T; Unno R; Machida T; Miyamura R; Saito I; Tahara T; Hosoi Y; Shimano E; Kotera K; Higashitsutsumi M
Jpn J Antibiot; 1979 Apr; 32(4):481-503. PubMed ID: 379383
[No Abstract] [Full Text] [Related]
58. Clinical studies of aztreonam in Japan.
Hara K; Kobayashi H; Nishiura T; Yura J; Saito A
Rev Infect Dis; 1985; 7 Suppl 4():S810-24. PubMed ID: 3909341
[TBL] [Abstract][Full Text] [Related]
59. Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Brogden RN; Heel RC
Drugs; 1986 Feb; 31(2):96-130. PubMed ID: 3512234
[TBL] [Abstract][Full Text] [Related]
60. Comparison of amikacin and gentamicin in the treatment of urinary tract infections.
Gilbert DN; Eubanks N; Jackson J
Am J Med; 1977 Jun; 62(6):924-9. PubMed ID: 868907
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
